How To Use CPT Code 90291

CPT 90291 describes the administration of cytomegalovirus immune globulin (CMV-IgIV) intravenously to provide short-term immunity against cytomegalovirus. This article will cover the description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, similar codes and billing examples.

1. What is CPT Code 90291?

CPT 90291 can be used to describe the intravenous administration of cytomegalovirus immune globulin (CMV-IgIV) to provide short-term immunity against cytomegalovirus. This code is used when the healthcare provider slowly administers the injection into the patient’s vein using an appropriately sized needle.

2. Official Description

The official description of CPT code 90291 is: ‘Cytomegalovirus immune globulin (CMV-IgIV), human, for intravenous use.’

3. Procedure

1. The healthcare provider selects an appropriately sized needle for intravenous administration of CMV-IgIV.
2. The provider slowly administers the injection into the patient’s vein to provide short-term immunity against cytomegalovirus.

4. Qualifying circumstances

Patients eligible to receive CPT 90291 are those who require short-term immunity against cytomegalovirus. This procedure is typically used to prevent infection from cytomegalovirus. The healthcare provider must administer the CMV-IgIV intravenously using an appropriately sized needle.

5. When to use CPT code 90291

CPT code 90291 should be used when the healthcare provider administers cytomegalovirus immune globulin (CMV-IgIV) intravenously to provide short-term immunity against cytomegalovirus. This code should be used for each instance of intravenous administration of CMV-IgIV.

6. Documentation requirements

To support a claim for CPT 90291, the healthcare provider must document the following information:

• Patient’s need for short-term immunity against cytomegalovirus
• Date and time of the intravenous administration
• Details of the CMV-IgIV used
• Signature of the healthcare provider administering the procedure

7. Billing guidelines

When billing for CPT 90291, ensure that the healthcare provider administers cytomegalovirus immune globulin (CMV-IgIV) intravenously using an appropriately sized needle. There are no specific guidelines regarding reporting CPT 90291 with other codes.

8. Historical information

CPT 90291 was added to the Current Procedural Terminology system on January 1, 1999. There have been no updates to the code since its addition.

9. Examples

1. A healthcare provider administering cytomegalovirus immune globulin (CMV-IgIV) intravenously to a patient with a weakened immune system to prevent cytomegalovirus infection.
2. A nurse slowly administering CMV-IgIV intravenously to a newborn baby at risk of cytomegalovirus infection.
3. A physician administering CMV-IgIV intravenously to a transplant recipient to prevent cytomegalovirus infection.
4. A healthcare provider administering CMV-IgIV intravenously to a pregnant woman with cytomegalovirus to protect the fetus.
5. A nurse slowly administering CMV-IgIV intravenously to a patient undergoing chemotherapy to prevent cytomegalovirus infection.
6. A healthcare provider administering CMV-IgIV intravenously to a patient with a compromised immune system due to HIV/AIDS.
7. A nurse slowly administering CMV-IgIV intravenously to a premature baby at risk of cytomegalovirus infection.
8. A physician administering CMV-IgIV intravenously to a patient before a solid organ transplant to prevent cytomegalovirus infection.
9. A healthcare provider administering CMV-IgIV intravenously to a patient with a congenital immunodeficiency to prevent cytomegalovirus infection.
10. A nurse slowly administering CMV-IgIV intravenously to a patient undergoing a bone marrow transplant to prevent cytomegalovirus infection.